BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 34944728)

  • 1. Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism.
    Kim TH; Hong DG; Yang YM
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatokines and metabolism: Deciphering communication from the liver.
    Jensen-Cody SO; Potthoff MJ
    Mol Metab; 2021 Feb; 44():101138. PubMed ID: 33285302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Hepatokines in Non-alcoholic Fatty Liver Disease.
    Ke Y; Xu C; Lin J; Li Y
    J Transl Int Med; 2019 Dec; 7(4):143-148. PubMed ID: 32010600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implication of hepatokines in metabolic disorders and cardiovascular diseases.
    Jung TW; Yoo HJ; Choi KM
    BBA Clin; 2016 Jun; 5():108-13. PubMed ID: 27051596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis reveals exercise training induced remodelling of hepatokine secretion and uncovers syndecan-4 as a regulator of hepatic lipid metabolism.
    De Nardo W; Miotto PM; Bayliss J; Nie S; Keenan SN; Montgomery MK; Watt MJ
    Mol Metab; 2022 Jun; 60():101491. PubMed ID: 35381388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance.
    Meex RCR; Watt MJ
    Nat Rev Endocrinol; 2017 Sep; 13(9):509-520. PubMed ID: 28621339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic PTEN Signaling Regulates Systemic Metabolic Homeostasis through Hepatokines-Mediated Liver-to-Peripheral Organs Crosstalk.
    Berthou F; Sobolewski C; Abegg D; Fournier M; Maeder C; Dolicka D; Correia de Sousa M; Adibekian A; Foti M
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatokines as a Molecular Transducer of Exercise.
    Seo DY; Park SH; Marquez J; Kwak HB; Kim TN; Bae JH; Koh JH; Han J
    J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33498410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatokines and non-alcoholic fatty liver disease.
    Lebensztejn DM; Flisiak-Jackiewicz M; Białokoz-Kalinowska I; Bobrus-Chociej A; Kowalska I
    Acta Biochim Pol; 2016; 63(3):459-67. PubMed ID: 27262842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of hepatokines in NAFLD.
    Stefan N; Schick F; Birkenfeld AL; Häring HU; White MF
    Cell Metab; 2023 Feb; 35(2):236-252. PubMed ID: 36754018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the inter-organ crosstalk mediated by ChREBP.
    Carbinatti T; Régnier M; Parlati L; Benhamed F; Postic C
    Front Endocrinol (Lausanne); 2023; 14():1095440. PubMed ID: 36923222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between hepatokines and metabolic diseases.
    Liang JQ; Liu C; Zhang WX; Chen SY
    Yi Chuan; 2022 Oct; 44(10):853-866. PubMed ID: 36384723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatokines: unlocking the multi-organ network in metabolic diseases.
    Iroz A; Couty JP; Postic C
    Diabetologia; 2015 Aug; 58(8):1699-703. PubMed ID: 26032022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients - a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown.
    Iacob SA; Iacob DG
    Front Endocrinol (Lausanne); 2022; 13():814209. PubMed ID: 35355551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feeding-induced hepatokines and crosstalk with multi-organ: A novel therapeutic target for Type 2 diabetes.
    Chen RB; Wang QY; Wang YY; Wang YD; Liu JH; Liao ZZ; Xiao XH
    Front Endocrinol (Lausanne); 2023; 14():1094458. PubMed ID: 36936164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans.
    Peter A; Kovarova M; Staiger H; Machann J; Schick F; Königsrainer A; Königsrainer I; Schleicher E; Fritsche A; Häring HU; Stefan N
    Am J Physiol Endocrinol Metab; 2018 Mar; 314(3):E266-E273. PubMed ID: 29138227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of exercise-induced hepatokines in metabolic disorders.
    Ennequin G; Sirvent P; Whitham M
    Am J Physiol Endocrinol Metab; 2019 Jul; 317(1):E11-E24. PubMed ID: 30964704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatokines, bile acids and ketone bodies are novel Hormones regulating energy homeostasis.
    Garruti G; Baj J; Cignarelli A; Perrini S; Giorgino F
    Front Endocrinol (Lausanne); 2023; 14():1154561. PubMed ID: 37274345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Friend or foe for obesity: How hepatokines remodel adipose tissues and translational perspective.
    Zhang Y; Wang Y; Liu J
    Genes Dis; 2023 May; 10(3):825-847. PubMed ID: 37396511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of hepatokine and osteokine in liver-bone crosstalk: Advance in basic and clinical aspects.
    Li Z; Wen X; Li N; Zhong C; Chen L; Zhang F; Zhang G; Lyu A; Liu J
    Front Endocrinol (Lausanne); 2023; 14():1149233. PubMed ID: 37091847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.